Fed Circuit cancels skin cancer detection patent

The US Court of Appeals for the Federal Circuit has cancelled claims of a Melanoscan patent covering methods of detecting skin cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Coherus secures toripalimab rights for US and Canada

4 February 2021 Coherus Biosciences has signed a deal with Chinese biopharmaceutical company Shanghai Junshi Biosciences for the development and commercialisation rights to toripalimab, Junshi’s PD-1 inhibitor, in the US and Canada.

Big Pharma

Pfizer sues India generic drugmaker over cancer drug

14 January 2021 Pharmaceutical company Pfizer has accused generic drug maker Aurobindo of infringement, as it attempts to block the roll-out of copies of its blockbuster arthritis drug, Xeljanz.

More on this story

Big Pharma

Coherus secures toripalimab rights for US and Canada

Big Pharma

Pfizer sues India generic drugmaker over cancer drug

14 January 2021 Pharmaceutical company Pfizer has accused generic drug maker Aurobindo of infringement, as it attempts to block the roll-out of copies of its blockbuster arthritis drug, Xeljanz.

More on this story

Big Pharma

Coherus secures toripalimab rights for US and Canada

Big Pharma

Pfizer sues India generic drugmaker over cancer drug

14 January 2021 Pharmaceutical company Pfizer has accused generic drug maker Aurobindo of infringement, as it attempts to block the roll-out of copies of its blockbuster arthritis drug, Xeljanz.